{"schema":"sb.node.v1","id":"sb:e/fc1b4dfd141b620565707ee9","kind":"entity","label":{"text":"us fda","locale":"en"},"identity":{"anchor":"label:en:us fda","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-09T15:02:01.300955+00:00","snapshot":"deploy 715de3a33e8eeb86712a0099a2e16de711950fb3"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":62,"separatePublishers":14,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-14","to":"2026-10-08","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.613: about 39% of mentions carry no typed assertion"]}},"dimensions":{"domains":["fda_decisions","medical_devices","auto"],"activeDays":24,"assertions":{"regulatory-approval":31,"meeting-visit":2,"election":2,"launch-release":2,"utterance":1}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":6,"byKind":{"observation":6},"withheld":{"state":"withheld","count":6,"reason":"6 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/bd4b7b056485238dd504d714","kind":"observation","label":"AllSci News · 2026-10-07 · BridgeBio's oral infigratinib gets US FDA Priority Review in achondroplasia","url":"https://allsci.com/news/biotech/infigratinib-achondroplasia-fda-grants-priority/"},{"id":"sb:o/46c9fc06418d5630b3f757b8","kind":"observation","label":"AllSci News · 2026-10-05 · US FDA delays review of Novo hemophilia drug denecimig over manufacturing issue","url":"https://allsci.com/news/biotech/denecimig-approval-fda-manufacturing-review/"},{"id":"sb:o/d9cf93b95cdbcee71f7fea30","kind":"observation","label":"Renewable Carbon News · 2026-09-10 · Kelpi’s seaweed-based coating achieves US FDA food contact approval for packaging","url":"https://renewable-carbon.eu/news/kelpis-seaweed-based-coating-achieves-us-fda-food-contact-approval-for-packaging/"},{"id":"sb:o/19d7313bf0fcafe2b3fe2a4f","kind":"observation","label":"PR Newswire · 2026-09-03 · Legacy Healthcare Welcomes U.S. Congressional Legislation Proposing 12-Year Market Exclusivity for US FDA Newly Approved Botanical Drugs","url":"https://www.prnewswire.com/news-releases/legacy-healthcare-welcomes-us-congressional-legislation-proposing-12-year-market-exclusivity-for-us-fda-newly-approved-botanical-drugs-302868914.html"},{"id":"sb:o/73e01f206479bb60aa35a3da","kind":"observation","label":"AllSci News · 2026-10-08 · Ultragenyx to sell FDA priority review voucher for USD 210 million","url":"https://allsci.com/news/biotech/priority-review-voucher-ultragenyx-agrees-to-sell/"},{"id":"sb:o/8f063d5f6f32f3c2a2c23d53","kind":"observation","label":"Transportation · 2026-10-08 · Pharma supply chains need clean data before AI, says Cosette India head","url":"https://www.itln.in/pharma/pharma-supply-chains-need-clean-data-before-ai-says-cosette-india-head-1360881"}],"cursor":null,"order":"newest first; we keep the 6 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":12,"byKind":{"claim":2,"co-mentioned":10},"items":[{"id":"sb:p/ea54cf300c7ed81e0d081e09","kind":"claim","label":"US FDA delays review of Novo hemophilia drug denecimig over manufacturing issue — corroborated","role":"named-in","relationKind":"claim","members":1},{"id":"sb:p/82601684a4fd4e3332f14a9d","kind":"claim","label":"With FDA approval, Lilly’s BTK drug Jaypirca enters first-line CLL — corroborated","role":"named-in","relationKind":"claim","members":0},{"kind":"relation","label":"co-mentioned with fda (62 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/a48e11edd7999ae68d44c355"},{"kind":"relation","label":"co-mentioned with us food (15 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/13b2ea2d04f5f61d505a1ebd"},{"kind":"relation","label":"co-mentioned with marketing that performs (14 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/d1b4f4480c11ef76906d5a20"},{"kind":"relation","label":"co-mentioned with nasdaq (14 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/2cb940ca100fae3ef27f8803"},{"kind":"relation","label":"co-mentioned with studie (13 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/4e6028a919de9d725fa1a896"},{"kind":"relation","label":"co-mentioned with china (11 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/f03834b5e53bc7a8c54ace1b"},{"kind":"relation","label":"co-mentioned with europe (10 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/b6318ddae42c50abf7dd7843"},{"kind":"relation","label":"co-mentioned with ai (8 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/79b283a068b5fc207a1b0a57"}],"cursor":"c1.eyJpZCI6InNiOmUvZmMxYjRkZmQxNDFiNjIwNTY1NzA3ZWU5IiwibCI6InJlbGF0aW9ucyIsIm8iOjEwLCJrIjpudWxsLCJhIjoiMjAyNi0xMC0wOVQxNTowMjowMS4zMDA5NTUrMDA6MDAifQ","order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/fc1b4dfd141b620565707ee9","mcp":"traverse {\"id\":\"sb:e/fc1b4dfd141b620565707ee9\"}","page":"/entity/us-fda/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/fc1b4dfd141b620565707ee9\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/fc1b4dfd141b620565707ee9\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/fc1b4dfd141b620565707ee9\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/fc1b4dfd141b620565707ee9\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}